U.S. Markets closed

Peninsula biotech Rigel wins early drug approval as it lines up new HQ

Peninsula biotech Rigel wins early drug approval as it lines up new HQ

Only last week, the company was warned about its stock price; this week it's looking at putting a premium on the price of its second FDA-approved drug.